InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) Short Interest Update

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU - Get Free Report) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 215,400 shares, a drop of 7.8% from the March 31st total of 233,700 shares. Currently, 1.2% of the shares of the stock are sold short. Based on an average trading volume of 44,500 shares, the short-interest ratio is presently 4.8 days.

InfuSystem Trading Up 2.8 %

Shares of InfuSystem stock traded up $0.21 during mid-day trading on Wednesday, reaching $7.72. 23,438 shares of the stock were exchanged, compared to its average volume of 43,430. The stock has a market capitalization of $164.13 million, a P/E ratio of 250.42 and a beta of 1.24. The company has a quick ratio of 1.54, a current ratio of 1.95 and a debt-to-equity ratio of 0.56. InfuSystem has a fifty-two week low of $7.42 and a fifty-two week high of $11.44.

Institutional Investors Weigh In On InfuSystem

A number of hedge funds have recently made changes to their positions in INFU. WINTON GROUP Ltd acquired a new stake in InfuSystem in the 3rd quarter valued at about $101,000. Wasatch Advisors LP increased its position in InfuSystem by 3.4% in the 4th quarter. Wasatch Advisors LP now owns 846,609 shares of the medical instruments supplier's stock valued at $8,923,000 after acquiring an additional 27,881 shares in the last quarter. Citigroup Inc. increased its position in InfuSystem by 124.1% in the 3rd quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier's stock valued at $488,000 after acquiring an additional 28,038 shares in the last quarter. Punch & Associates Investment Management Inc. increased its position in InfuSystem by 3.2% in the 3rd quarter. Punch & Associates Investment Management Inc. now owns 939,918 shares of the medical instruments supplier's stock valued at $9,061,000 after acquiring an additional 28,807 shares in the last quarter. Finally, Ranger Investment Management L.P. increased its position in InfuSystem by 4.7% in the 4th quarter. Ranger Investment Management L.P. now owns 689,842 shares of the medical instruments supplier's stock valued at $7,271,000 after acquiring an additional 30,835 shares in the last quarter. Institutional investors and hedge funds own 71.13% of the company's stock.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a research report on Monday.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.